Trade News

Basel, July 04, 2005

Roche Diagnostics introduces cobas IT 1000 solution a new web based data management solution for Point of Care testing in hospitals

Open IT system will make quality assurance for Point of Care testing in hospitals easy

Today Roche Diagnostics announced the global roll*out of the cobas IT 1000 solution. This data management IT solution is an open system that connects Point of Care devices from Roche Diagnostics’ as well as devices from other suppliers - within one hospital or even in a hospital network. Healthcare professionals will be able to spend more time with their patients and less time organizing and managing their patient test data and quality control results.  They can access their data from wherever they are through innovative web based technology.

"The cobas IT 1000 solution represents a major step forward in our overall target to improve medical treatment as well as the quality of patient’s lives through innovative diagnostics solutions. This product will make high quality actionable health information from on the spot diagnostic measurements available, everywhere and whenever needed" underlined Dr. Giuseppe Minola, Head of Roche Near Patient Testing, a business area of Roche Diagnostics.

The cobas IT 1000 solution will support customers to better cope with the requirements by regulatory and accreditation guidelines as it enables them to easily track their patient and quality control data and provide it on demand to authorities.

About cobas 1000 IT solution
The cobas IT 1000 solution allows for management of system configurations, test and material management, operator and Point of Care instrument management as well as quality control and extensive reporting functions.

About Roche and the Roche Diagnostics Division
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is a world leader in diagnostics, the leading supplier of medicines for cancer and transplantation and a market leader in virology. In 2004 sales by the Pharmaceuticals Division totaled 21.7 billion Swiss francs, while the Diagnostics Division posted sales of 7.8 billion Swiss francs. Roche employs roughly 65,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai.

Roche’s Diagnostics Division offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories world-wide. For further information, please visit our websites and

cobas is a trademark of Roche.

* Outside the US market